Evidence map›Paper›PMID 41403863›Full record

ArticleOchsner journal2025

Cobalt Toxicity Presenting as Bilateral Optic Neuropathy.

Fatima-Tun-Nissa Raza, Can Kocasarac

Abstract readCase Reports
In one paragraph

Article in Ochsner journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fatima-Tun-Nissa RazaDepartment of Neuro-Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, PA.
Can KocasaracDepartment of Ophthalmology, Duke University Medical Center, Durham, NC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cobalt, a ferromagnetic metal with a wide range of uses, has been known to cause systemic toxicity in humans that results in thyroid dysfunction, cardiomyopathy, hematologic abnormalities, and neuropathy. Arthroprosthetic cobaltism is a term used to describe systemic cobalt toxicity originating from cobalt-containing prosthetic joints. Ocular toxicity from elevated serum levels of cobalt is a rare phenomenon. Case Report: We describe a case of bilateral toxic optic neuropathy resulting from a damaged cobalt-containing shoulder prosthesis in a 76-year-old female. The patient exhibited classic clinical findings of toxic optic neuropathy, with painless insidious vision loss, dyschromatopsia, and bilateral central scotomas. Clinical testing showed a progressive reduction in the thickness of the peripapillary retinal nerve fiber layer and ganglion cell complex on optical coherence tomography. Magnetic resonance imaging of the brain and orbits without contrast were unrevealing. Extensive laboratory testing ruled out infectious, inflammatory, demyelinating, and nutritional causes of optic neuropathy. However, slightly elevated levels of serum cobalt were found. Considering the possibility of arthroprosthetic cobaltism, arthrocentesis from the patient's shoulder prosthesis was performed and revealed that the cobalt levels in her synovial fluid were 35 times higher than the normal limit. Replacement of the damaged prosthetic joint resulted in a decrease in the patient's serum cobalt levels and improvement of her vision. Conclusion: While arthroprosthetic cobaltism from hip joints has been reported, to our knowledge, ours is the first case to prove a damaged shoulder prosthesis was the etiology. The patient's relatively low levels of serum cobalt and the lack of systemic features are also intriguing.

Indexed as

Arthroplasty–replacement–shoulderelectroretinographyoptic nervescotomastoxic optic neuropathy

Identifiers

PMID41403863
PMCPMC12704472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.